BIT036- a likely candidate for curing COVID-19, page-792

Biotron have been underperforming for over 10 years and do not have the resources or the tech to produce any profit let alone revenue

Hence why they engage so many third parties. BIT has nothing to show after more than 10 years in the industry. Big Pharma tend to partner with universities, or go inhouse to do their R&D. Its sooooo much cheaper for them and most probably...reliable

BIT will putting their hands out to shareholders very soon to pay for impacts of delays as result of poor performance and covid-19 restrictions

MnM just doesn't report to BIT's shareholders. She treats this PUBLIC company as her personal ticket to a luxurious retirement

Too many chiefs in this company that fail to perform for holders